SOPHiA Buys In More Bioinformatics Know-How For Cancer Genomics
Executive Summary
In a move to accelerate adoption of its AI-driven genomics platform, SOPHiA Genetics has acquired Interactive Biosoftware, the French developer of Alamut, a clinical decision support software used in genomic data interpretation.
You may also be interested in...
SOPHiA Genetics Combines In Vivo And In Vitro Cancer Analyses With Enhanced AI Platform
Clinical genomics company SOPHiA Genetics is integrating new radiomics capabilities to enhance its artificial intelligence (AI) platform SOPHiA, which is already used for analyses of oncology data from liquid biopsy tests. The news marks an increasing trend toward integrating in vivo and in vitro data onto a single diagnostic platform.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.